Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vardenafil Daily vs PRN in ED
NCT00786253Phase 2Completed
- Sponsor
- Bayer
- Start
- Oct 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of vardenafil in erectile dysfunction (ED) (3 arms), sponsored by Bayer. Primary endpoint: International Index of Erectile Function - Erectile Function Domain Change Score at 24 weeks. Started Oct 2005; status: completed.
02
Drugs
vardenafil
03
Conditions
erectile dysfunction (ED)
Beyond the preview
Go deeper on NCT00786253.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00786253.